Built from Within: How Local Capital Shapes Global Biotech Hubs
Biotech may be global in ambition, but ecosystems thrive when capital arrives and stays.
Biotech may be global in ambition, but ecosystems thrive when capital arrives and stays.
A conversation with Dr. Uli Stilz, Head of Bio Innovation Hub at Novo Nordisk.
A conversation with Dr. Marina Gerner, journalist and author of The Vagina Business
Explore how to identify entrepreneurial academics in biotech using key metrics like startup leadership, patents, and research grants.
A conversation with Luke Timmerman, award-winning biotech journalist and founder of the Timmerman Report.
This report highlights the leading biotechnology venture capitalists in the Chicagoland area and provides an overview of its biotech investment landscape.
Brazilian VC funding in biotech is on the rise, with approximately 50 firms investing in a diverse range of biotech sectors.
Introduction to the Nucleate Biotech Ecosystem Insights Series.
The human story of biotechnology, and how it will change life as we know it.
A conversation with Armand Cognetta, CEO & founder of General Proximity
Biotech may be global in ambition, but ecosystems thrive when capital arrives and stays.
A conversation with Hilary Schultz and Dr. William Heath, CEO and CSO at Persephoni BioPartners
Written by Liz Hughes, Gohta Aihara, Clara Brouaux, Kenza Mourji, Maggie Wang, & Lauren Stanwicks About This Article This article is part of Nucleate’s Global Life Sciences series and accompanies our recent event “Los Angeles × Paris: Life Sciences Across Continents”, which brought together leaders from two rising biotech ecosystems....
A conversation with Dr. William Pao, former CDO of Pfizer
A conversation with Dr. Campbell, CSO of Quotient Therapeutics